Blood type and blood disorders are closely related aspects of human health. The ABO blood group system classifies blood types based on specific antigens on red blood cells, while the Rh factor determines another blood type component. Understanding one's blood type is important in assessing the risk and managing various blood disorders like anemia, hemophilia, and sickle cell disease.
Sort by title | Sort by title | Sort by price | Sort by price
The AChR antibody test measures antibodies targeting acetylcholine receptors in the body, crucial for muscle movement. It helps diagnose myasthenia gravis, an autoimmune condition causing muscle weakness. Results can confirm the disease, but not all patients show antibodies. The test also aids in treatment monitoring and distinguishing neuromuscular disorders. Consult a healthcare provider for result interpretation and appropriate treatment, which may involve medication and immunosuppressants.
An autoimmune disorder panel consists of blood tests used to diagnose and monitor autoimmune diseases by measuring levels of antibodies and other substances associated with these conditions. Common tests include ANA, RF, anti-DNA antibodies, anti-CCP antibodies, ESR, and CRP tests. These tests are ordered together to assess the immune system comprehensively, aiding in diagnosis and treatment of autoimmune diseases.
A Basic Health Panel includes a Comprehensive Metabolic Panel (CMP), Urinalysis (UA), and Lipid Panel (LP). The CMP measures body chemical balance, detecting conditions like diabetes and kidney disease. The UA tests urine for kidney function and infections. The LP measures cholesterol levels, assessing heart disease risk. The panel provides crucial health information and is commonly used for routine screenings
The Blood Type Test, also known as ABO Grouping and Rh Typing, identifies an individual's blood type based on antigens on red blood cells. ABO group (O, A, B, AB) and Rh factor (positive/negative) are determined. This test is vital for blood transfusions, organ transplants, and compatibility between donors and recipients. It involves a blood sample collection and lab analysis. Results guide medical procedures and emergencies, ensuring safe transfusions and treatment. Blood type compatibility is critical to prevent adverse reactions. Knowing one's blood type can also offer insights into inherited conditions. The Blood Type Test is essential in healthcare to maintain safe practices during medical interventions.
The CA-125 test measures levels of the CA-125 protein in the blood, with elevated levels potentially indicating ovarian cancer. However, other conditions can also cause elevated CA-125 levels. The test is used alongside other tests and imaging to diagnose, monitor, and assess response to treatment for ovarian cancer.
A Comprehensive Health Panel, including a CBC, CMP, UA, LP, Iron, and TSH tests, offers detailed insight into your health status. The CBC assesses blood components, while the CMP focuses on metabolic and organ function. Urinalysis checks for various conditions, the Lipid Panel measures cholesterol levels, and the Iron Panel evaluates iron markers. TSH testing assesses thyroid function. This panel provides a comprehensive health assessment and aids in diagnosing and monitoring medical conditions, making it beneficial for routine check-ups or investigating specific symptoms.
A lupus panel is a set of blood tests used for diagnosing and monitoring lupus, an autoimmune disease. It includes tests for specific antibodies, complement levels, and markers of inflammation. These tests aid in assessing the presence and severity of lupus, tracking disease activity, and determining treatment response.
Prothrombin Time (PT) with International Normalized Ratio (INR) is a blood test that measures blood clotting time by evaluating prothrombin proteins. The INR standardizes results to ensure consistency across tests. It is vital for monitoring patients on anticoagulant medications like warfarin, adjusting dosages to balance clotting and bleeding risks. Higher INR values indicate slower clotting, increasing bleeding risk, while lower values suggest clot formation risk. PT with INR is crucial for managing conditions requiring anticoagulant therapy, such as deep vein thrombosis. Regular testing helps providers assess clotting status, make treatment adjustments, and prevent complications.
Sickle cell anemia screening is a test that identifies whether a person carries the sickle cell trait or has the disease. Sickle cell anemia is an inherited red blood cell disorder where the hemoglobin protein responsible for carrying oxygen is abnormal, causing the red blood cells to become crescent-shaped and stiff. The screening test involves analyzing a blood sample to check for the presence of abnormal hemoglobin. This screening is essential for identifying individuals at risk of passing the trait to their children and for implementing preventive measures and early interventions to manage the condition.
A standard health panel typically includes tests like Complete Blood Count (CBC), Comprehensive Metabolic Panel (CMP), Urinalysis (UA), Lipid Panel (LP), and Thyroid-Stimulating Hormone (TSH). These tests provide information about blood cell levels, kidney and liver function, urinary health, heart disease risk, and thyroid function. The panel is used for routine health screening and to evaluate overall health and specific conditions, providing important information for healthcare providers to assess and guide further treatment decisions.
USLABTESTING